Edition:
United Kingdom

Intellia Therapeutics Inc (NTLA.OQ)

NTLA.OQ on NASDAQ Stock Exchange Global Market

29.28USD
21 Aug 2018
Change (% chg)

$1.54 (+5.55%)
Prev Close
$27.74
Open
$27.60
Day's High
$29.40
Day's Low
$27.60
Volume
224,670
Avg. Vol
271,822
52-wk High
$35.99
52-wk Low
$15.25

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 7.68 -0.519
Mar '18 7.47 -0.508
FY 2017 Dec '17 6.67 -0.611
Sep '17 7.32 -0.436
Jun '17 5.92 -0.447
Mar '17 6.22 -0.364
FY 2016 Dec '16 5.63 -0.305
Sep '16 4.87 -0.218
Jun '16 4.21 -0.361
Mar '16 1.78 -0.191
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-18 5 11.84 25.40 7.12 13.45
Quarter Ending Dec-18 5 12.28 17.90 7.32 13.85
Year Ending Dec-18 6 37.87 58.40 29.59 38.55
Year Ending Dec-19 5 35.92 56.00 25.00 38.80
Earnings (per share)
Quarter Ending Sep-18 6 -0.47 -0.15 -0.63 -0.42
Quarter Ending Dec-18 6 -0.50 -0.39 -0.59 -0.47
Year Ending Dec-18 6 -2.00 -1.56 -2.25 -1.93
Year Ending Dec-19 6 -2.46 -1.94 -3.15 -2.56
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 85.69 32.76
P/E High - Last 5 Yrs. -- 300.66 45.44
P/E Low - Last 5 Yrs. -- 92.08 24.26
Beta -- 0.93 0.89
Price to Sales (TTM) 49.36 114.99 5.75
Price to Book (MRQ) 5.95 15.52 5.00
Price to Tangible Book (MRQ) 5.95 14.52 6.57
Price to Cash Flow (TTM) -- 72.88 23.29
% Owned Institutions 47.11 14.70 2.21

Dividends

  Company industry sector
Dividend Yield -- 0.36 1.51
Dividend Yield - 5 Year Avg -- 0.26 1.52
Dividend 5 Year Growth Rate -- 1.72 5.22
Payout Ratio(TTM) -- 16.50 43.78

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 40.68 411.56 8.01
Sales (TTM) vs TTM 1 Yr. Ago 141.65 80.51 5.64
Sales - 5 Yr. Growth Rate -- 32.27 10.18
EPS (MRQ) vs Qtr. 1 Yr. Ago -23.76 29.15 20.60
EPS (TTM) vs TTM 1 Yr. Ago -69.49 -- --
EPS - 5 Yr. Growth Rate -- 39.85 10.66
Capital Spending - 5 Yr. Growth Rate -- 40.43 15.34

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.91 2.22
Current Ratio (MRQ) 9.33 5.46 3.03
LT Debt to Equity (MRQ) 0.00 35.26 12.51
Total Debt to Equity (MRQ) 0.00 37.08 16.85
Interest Coverage (TTM) -- -102.36 32.63

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 39.17 54.37
Gross Margin - 5 Yr. Avg. -- 50.57 52.17
EBITD Margin (TTM) -200.83 -- --
EBITD - 5 Yr. Avg -- -600.69 10.68
Operating Margin (TTM) -209.85 -759.79 4.32
Operating Margin - 5 Yr. Avg. -- -621.72 6.11
Pre-Tax Margin (TTM) -204.48 -733.64 5.18
Pre-Tax Margin - 5 Yr. Avg. -- -627.42 6.51
Net Profit Margin (TTM) -204.48 -735.01 1.48
Net Profit Margin - 5 Yr. Avg. -- -630.47 2.78
Effective Tax Rate (TTM) -- 23.33 23.11
Effective Tax Rate - 5 Yr. Avg. -- 18.66 23.97

Efficiency

  Company industry sector
Revenue/Employee (TTM) 217,577 23,231,105 860,375,625
Net Income/Employee (TTM) -444,894 3,144,294 101,207,245
Receivable Turnover (TTM) 12.02 20.89 5.87
Inventory Turnover (TTM) -- 2.46 3.41
Asset Turnover (TTM) 0.08 0.41 0.94

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -16.08 -0.16 11.13
Return on Assets - 5 Yr. Avg. -- 3.51 12.40
Return on Investment (TTM) -17.54 1.78 14.61
Return on Investment - 5 Yr. Avg. -- 2.56 16.13
Return on Equity (TTM) -22.51 3.28 16.33
Return on Equity - 5 Yr. Avg. -- 3.42 17.39
  1 Year 3 Year 5 Year
Sales % 172.65 -- --
EPS (TTM) % -303.01 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Intellia Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 39.32 34.52 99 53
13 Week 86.55 77.47 99 66
26 Week 126.26 109.06 99 80
52 Week 87.00 58.50 99 50
YTD 135.93 107.19 99 61
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 68.03%
# of Holders: 216
Total Shares Held: 29,389,074
3 Mo. Net Change: 2,618,402
# New Positions: 48
# Closed Positions: 22
# Increased Positions: 130
# Reduced Positions: 49
# Net Buyers: 81
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.